Presutti, D.Agarwal, T.bZarepour, A.Celikkin, N.Hooshmand, S.Zarrabi, Ali2022-01-182022-01-182022Presutti, D., Agarwal, T., Zarepour, A., Celikkin, N., Hooshmand, S., Nayak, C., . . . Maiti, T. K. (2022). Transition metal dichalcogenides (TMDC)-based nanozymes for biosensing and therapeutic applications. Materials1996-1944https://doi.org/10.3390/ma15010337https://hdl.handle.net/20.500.12713/2394Nanozymes, a type of nanomaterial with enzyme-like properties, are a promising alternative to natural enzymes. In particular, transition metal dichalcogenides (TMDCs, with the general formula MX2, where M represents a transition metal and X is a chalcogen element)-based nanozymes have demonstrated exceptional potential in the healthcare and diagnostic sectors. TMDCs have different enzymatic properties due to their unique nano-architecture, high surface area, and semiconducting properties with tunable band gaps. Furthermore, the compatibility of TMDCs with various chemical or physical modification strategies provide a simple and scalable way to engineer and control their enzymatic activity. Here, we discuss recent advances made with TMDC-based nanozymes for biosensing and therapeutic applications. We also discuss their synthesis strategies, various enzymatic properties, current challenges, and the outlook for future developments in this field. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.eninfo:eu-repo/semantics/openAccessAnticancerAntimicrobialBiosensingCytoprotectionNanozymesTransition metal dichalcogenidesReview Article15135009484WOS:0007436826000012-s2.0-85122237125Q210.3390/ma15010337Q2